Vnitr Lek 2008, 54(2):135-136

Je dyslipidemie rizikovým faktorem pro nemocné léčené antiretrovirovými léky? - editorial

V. Soška
Oddělení klinické biochemie FN u sv. Anny Brno, prim. doc. MUDr. Vladimír Soška, CSc.

Received: August 30, 2007; Published: February 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Soška V. Je dyslipidemie rizikovým faktorem pro nemocné léčené antiretrovirovými léky? - editorial. Vnitr Lek. 2008;54(2):135-136.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Soška V. Sekundární dyslipidemie a jejich léčba. Vnitř Lék 2007; 53: 396-400. Go to PubMed...
    2. Sammalkorpi K, Valtonen V, Kerttulla Y et al. Changes in serum lipoprotein induced by acute infections. Metabolism 1988; 37: 859-865 Go to original source... Go to PubMed...
    3. Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 329-337. Go to original source... Go to PubMed...
    4. Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992; 41 Suppl 2: 97-101. Go to original source... Go to PubMed...
    5. Read TE, Harris HW, Grunfeld C et al. The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Eur Heart J 1993; 14 Suppl K: 125-129. Go to PubMed...
    6. Vaverková H, Soška V, Rosolová H et al. Doporučení pro diagnostiku a léčbu dyslipidémií v dospělosti, vypracované výborem České společnosti pro aterosklerózu. Vnitř Lék 2007; 53: 181-197. Go to PubMed...
    7. Snopková S et al. Dyslipidemie indukovaná antiretrovirovými léčivy. Vnitř Lék 2008; 54(2): 169-177. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.